The Eurasian Journal of Medicine and Oncology (EJMO) is published every three months and one volume consists of four issues. The journal publishes Medical Oncology, Allergy and Immunology, Adolescent Medicine, Anaesthesiology, Aerospace Medicine, Pathology, Cardiology, Cardiothoracic Surgery, Child and Adolescent Psychiatry and Psychotherapy, Clinical Neurophysiology, Colon and Rectal Surgery, Dermatology-Venereology, Emergency Medicine, Endocrinology, Gastroenterology, General Practice, Geriatrics, Obstetrics and Gynaecology, Health Informatics, Hospice and palliative Medicine, Infectious Disease, Internal Medicine, Interventional Radiology, Vascular Medicine, Microbiology, Nephrology, Neurology, Neurosurgery, Nuclear Medicine, Occupational Medicine, Ophthalmology, Orthodontics, Orthopaedics, Oral and Maxillofacial Surgery, Otorhinolaryngology, Paediatrics, Paediatric Allergology, Paediatric Cardiology, Paediatric Endocrinology and Diabetes, Paediatric Gastroenterology, Hepatology and Nutrition, Paediatric Haematology and Oncology, Paediatric Infectious Diseases, Neonatology, Paediatric Nephrology, Paediatric Respiratory Medicine, Paediatric Rheumatology, Paediatric Surgery, Physical Medicine and Rehabilitation, Plastic, Reconstructive and Aesthetic Surgery, Pulmonology, Psychiatry, Public Health, Radiation Oncology, Radiology, Sports Medicine, Neuroradiology, General Surgery, Urology and Related subjects in the field of original research, case report, reviews and letters to the editor are published in English.
Articles which are not previously published in another journal or not currently under evaluation elsewhere can be accepted for the journal. Articles approved by the Scientific Committee and Editorial Board are eligible to be released after receiving at least two positive opinions from the Scientific Committee members of the EJMO. Those committees have the authority to make all corrections and abbreviations but not to change the content of the article.
The authors have the all the scientific and legal responsibilities of the manuscripts. The authors must fully obey the ethics of research and publication.
All published material will become the sole property and will be copyrighted by the Journal. No part of the publication may be used without prior written permission of the publisher. Articles and illustrations become the property of the Journal after publication.
There is no fee for article submission, article processing or publication.
Registration and login are required to submit items online and to check the status of current submissions. Users should visit journal’s web site (www.ejmo.org) and create an account before submitting their manuscripts.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
EJMO publishes as english original research, case report, reviews and letters to the editör medicine-related. Contributions may be in the form of clinical and basic research articles, case reports, personal clinical and technical notes, and letters to the Editor. The Journal also publishes brief reports on original studies or evaluations, book reviews, and proceedings of scientific meetings. Opinions presented in published articles by no means represent the official endorsement of the EJMO. The Editor-in-Chief may request from the authors additional data, information, or complementary material concerning the manuscripts and the authors must comply with such requests.
Manuscripts should be prepared in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” regularly updated by the International Committee of Medical Journal Editors (ICMJE), available at http://www.icmje.org.
EJMO expects the authors to comply with the ethics of research and publication. In human research, a statement of the informed consent of those who participated in the study is needed in the section of the “Materials and Methods”.
All studies should be carried out in accordance with the World Medical Association Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/), covering the latest revision date. Patient confidentiality must be protected according to the universally accepted guidelines and rules. In case of procedures that will apply to volunteers or patients, it should be stated that the study objects have been informed and given their approval before the study started. In case the authors do not have a local ethics committee, the principles outlined in the “Declaration of Helsinki” should have been followed. Authors should declare that they have followed the internationally accepted latest guidelines, when asked legislation and other related regulations and should sent “Approval of the Ethics Committee”.
Manuscripts reporting the results of experimental studies on animals must include a statement that the study protocol was approved by the animal ethics committee of the institution and that the study was conducted in accordance with the internationally accepted guidelines, including the Universal Declaration of Animal Rights, European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Principles of Laboratory Animal Science, and the Handbook for the Care and Utilization of Laboratory Animals. Authors are strongly requested to send a record of the approval of the ethics committee with the manuscript. Furthermore, manuscripts on human and animal studies should describe procedures indicating the steps taken to eliminate pain and suffering.
The manuscripts are scanned by the Publishers Office using the iThenticate program for determination of plagiarism and non-ethical situations.
The official language of the Journal is English. All submissions and correspondence throughout the review process must be conducted in English.
A technical review is performed to confirm that all of the required documentation has been submitted and to conduct a preliminary evaluation of the manuscript and supplementary files to assess suitability for the Journal. The manuscript will be returned to the Author in the event of any deficiency.
The Editorial Office of EJMO then assigns the manuscript a number and begins the peer preview process. This journal operates a blind review process. Contributions deemed suitable are then typically sent to a minimum of two independent expert reviewers in the field of study to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.
Corrections may be made to a published article with the authorization of the editor of the journal. Editors will decide the magnitude of the corrections. Minor corrections are made directly to the original article. However, in cases of major corrections, the original article will remain unchanged, while the corrected version will also be published and linked to the corrected version. A statement indicating the reason for the major change to the article will also be published. When necessary, retraction of articles will be done according to the Committee on Publication Ethics (COPE) retraction guidelines. https://publicationethics.org/resources/guidelines. If authors withdrove articles in any time after review and acceptance, they have to pay 100$ withdrawal fee. If authors retract published manuscripts , they have to pay 500 $ per retraction.
The authors should disclose all issues concerning financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgment. All financial contributions or sponsorship, financial relations, and areas of conflict of interest should be clearly explained in a separate letter to the editor at the time of submission, with full assurance that any related document will be submitted to the Journal when requested.
Manuscripts should be sent with the Copyright-Authors’ Approval-Conflict of Interest Letter signed by the author(s). A copy of this letter can be found at www.ejmo.org. Manuscripts will not be accepted for evaluation until the receipt of this document by the Journal.
Manuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals regularly updated by the International Committee of Medical Journal Editors, available at http://www.icmje.org.
Submission and tracking of a manuscript can only be made online through the http://www.ejmo.org web site at https://mc04.manuscriptcentral.com/ejmo. Corresponding author should register to https://mc04.manuscriptcentral.com/ejmo web site and login to start a submission process.
Material and methods
Material and methods
Conflict of interest:
Before the corresponding author submits the manuscript, all authors must obtain ORCID ID number and provide it to the corresponding author.
The “Copyright Transfer Form” after being signed by all authors should be uploaded using the article accepting system of the EJMO.
The title of article, short title, author name(s), names of institutions and the departments of the authors, full address, telephone numbers (landline and mobile) and e-mail address should be given. The title should be short and written in lower case. In addition, the running title should be written and it should not exceed 40 characters.
The microorganism’s Latin names of used for the first time in the text have to be written in full. If these names are used later, they should be abbreviated in accordance to international scientific rules. The original Latin names of microorganisms should be written in Italic style: for example, Staphyloccoccus aureus, S.aureus. The antibiotics’ names should be abbreviated in accordance with international standards and they should be used with generic names.
Symbols of the international units mentioned in the text should be according to “The Systeme International (SI).
Manuscripts should be written in one of the “past perfect, present perfect and past tenses” and in the passive mode.
A4 paper should be used and should have a 2.5 cm margin on each side. Times New Roman font, 12 pt, and double lines space should be used.
EJMO expects the authors to comply with the ethics of research and publication. In human research, a statement of the informed consent of those who participated in the study is needed in the section of the “Materials and Methods”. In case animal studies, approval also is needed. Please, see at: Ethical issue.
In Original Articles; Research/Original manuscripts should consist of English abstract.
Introduction, Materials and Methods, Results, Discussion, Acknowledgements (if any), and References sections. These sections should be written in bold capital letters and aligned left.
Abstract: The abstract should be structured like the Objective, Methods, Results, and Conclusion. It should be between 300 and 400 words.
Keywords: The number of keywords should be between 3-6 and the terminology of the Medical Subjects Headings (Index Medicus Medical Subject Headings - MeSH) should be used. Please check at: https://www.nlm.nih.gov/mesh/MBrowser.html
Introduction: The aim of the study, and references given to similar studies should be presented briefly and should not exceed more than two pages.
Materials and Methods: The date of the study, institution that performed the study, and materials and methods should be clearly presented. Statistical methods should be clearly stated. All research manuscripts will send to professional statistician for their statistical evaluation by the Editor.
Results: The results should be stated clearly and only include the current research.
Conclusions: In this section, the study findings should be compared with the findings of other researchers. Authors should mention their comments in this section.
Acknowledgements: Acknowledgements should be placed at the end of the main text and before the references. In this section, the institutions/departments and person which supported the research should be stated. I) The study supported by a fund or scientific organization must be mentioned in the acknowledgements. II) The study presented in a conference/symposium must be mentioned with the type of presentation in the acknowledgements.
References: Authors are responsible for supply complete and correct references. References should be numbered according to the order used in the text.
Numbers should be given in brackets and placed at the end of the sentence. Examples are given below on the use of references. reference end note style Vancouver
Periodicals: Author(s) Last Name initial(s) name of author(s) (if there are six or fewer authors, all authors should be written; if the number of authors are seven or more, only the first six of the authors should be written and the rest as “et al”). The title of the article, the abbreviated name of the journal according to the Index Medicus, Year; Volume (Issue): The first and last page numbers.
Robson A, Greene J, Ansari N, Kim B. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. The American Journal of Surgical Pathology. 2001;25:710-20.Books: Surname of the author(s) initial name(s) of author(s). The name of the book. The edition number. Place of publication: Publisher, Publication year.
Book chapters: The author (s) surname of the chapter initial (s) letter of the name. Section title. In: Surname of editor (s) initial (s) letter of first name (s) ed / eds. The name of the book. Edition number. Place of publication: Publisher, year of publication: The first and last page numbers of the chapter.
Web address: If a “web” address is used as the reference address, the web address date should be given in brackets with the address. The DOI (Digital Object Identifier) number must be provided, when a web access article used in the text as a reference.
Example: AB Author, CD Author. Title of document. Retrieved from http://Web address (Accession date: aa/bb/2016).
Thesis: Maden KL. Experimental investigation of the â¦â¦â¦â¦â¦.. Master Thesis, Health Science Institute of Ankara University, Ankara, 2005.
Figure and Tables:Each table or figure should be printed on a separate sheet, the top and bottom lines and if necessary column lines must be included.
Tables should be numbered like “Table 1.” and the table title should be written above the top line of the table. Explanatory information should be given in footnotes, not in the title and appropriate icons (*,+,++, etc.) should be used.
Photos should be in “JPEG” format. In case the quality of the photos is not good for publication, the originals can be requested.
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
All authors must obtain ORCID ID number and provide it to the corresponding author.
Abstract, 250- 500 words or shorter
Manuscript without abstract, structured correctly
References at the end of the manuscript, listed in order of citation
All figures sent separately and not embedded in the manuscript
Figure legends included at the end of the manuscript
All figures and tables are cited in the manuscript
A letter of copyright transfer, signed by all authors
Endnote reference style:Vancouver
This is an open access journal, which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full text of the articles in EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY (EJMO) without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The BOAI arose from a meeting convened in Budapest by the Open Society Institute (OSI) on December 1-2, 2001. The purpose of the meeting was to accelerate progress in the international effort to make research articles in all academic fields freely available on the Internet. The participants represented many points of view, many academic disciplines, many nations, and had experience with many of the ongoing initiatives that make up the open access movement. In Budapest, they explored how the separate initiatives could work together to achieve broader, deeper, and faster success. They explored the most effective and affordable strategies for serving the interests of research, researchers, and the institutions and societies that support research. Finally, they explored how the OSI and other foundations could use their resources most productively to aid the transition to open access and to make open access publishing economically self-sustaining. The result was the BOAI. It is at once a statement of principle, a statement of strategy, and a statement of commitment.
When an author chooses to make their article open access, their article is made free to read and reuse immediately upon publication under a Creative Commons Attribution-NonCommercial 4.0 (CC BY NC) license. This allows users to copy and distribute the article, provided this is not done for commercial purposes. It further does not permit distribution of the article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work.
EJMO aims to provide quality, peer-reviewed, open access articles to thousands of physicians. The journals include papers on all of the related areas of basic and clinical medicine.
Ethical Responsibilities of Editors
The editor and field editors of EJMO should uphold the following ethical responsibilities that are based on the COPE Code of Conduct and Best Practice Guidelines for Journal Editors and COPE Best Practice Guidelines for Journal Editors.
General Duties and Responsibilities
Editors are responsible for each study published in EJMO. In this respect, the editors have the following roles and responsibilities:
Relationships with Readers
Editors must make decisions taking into consideration the knowledge, skills, and expectations of all readers, researchers, and practitioners. They must also ensure that published studies are original and contribute to the literature. Moreover, they must take notice of the responses received from researchers and practitioners and provide explanatory and informative feedback.
Relationships with Authors
Editors have the following duties and responsibilities in their relations with authors:
Relationships with Reviewers
Editors have the following duties and responsibilities in their relations with reviewers:
Relationships with the Editorial Board
Editors must make sure that the members of the editorial board follow procedures in accordance with the publication policies and guidelines, and must inform members about publication policies and developments. The editors must also train new members of the editorial board and provide the information they need.
Moreover, editors must
Relationships with the Journal Owner and Publisher
The relationship between the editors and the publisher is based on the principle of independence of the editors. All of the decisions made by the editors are independent of the publisher and the owner of the journal, as required by the agreement made between the editors and the publisher.
Editorial and Blind Review Processes
Editors are obliged to comply with the blind review and review process as stated in the journal's publication policies in order to ensure that each manuscript is reviewed in an unbiased, fair, and timely manner.
Editors must make sure that articles in the journal are published in accordance with the publication policies of the journal and international standards.
Protection of Personal Information
Editors are to protect the personal information of study participants and to reject a manuscript if there is no documentation of the participants' consent. Furthermore, editors are also to protect the personal information of authors, reviewers, and readers.
Ethics Approval and Protection of Human and Animal Rights
Editors are to ensure protection of human and animal rights in the studies being reviewed and must reject experimental studies that do not have the approval of the appropriate ethics committee and other relevant bodies.
Precautions against possible Abuse and Malpractice
Editors are to take precautions against possible abuse and malpractice. They must conduct investigations of alleged misconduct meticulously and objectively and must also share the results of the investigation.
Ensuring Academic Integrity
Editors must make sure that any errors, inconsistencies, or misleading information in studies is corrected quickly.
Protection of Intellectual Property Rights
Editors are responsible for protecting the intellectual property rights related to all articles published in the journal, and the rights of the journal and author(s) in cases where these rights are violated. Also, editors must take the necessary precautions to ensure that the content of published articles does not violate the intellectual property rights of other publications.
Constructiveness and Openness to Discussion
Editors must examine complaints received from authors, reviewers, or readers, and must provide an explanatory response.
The independent decision-making of the editors cannot be subjected to influence by the owner of the journal, the publisher, or any other external political or economic factor.
The editors, acknowledging that there may be conflicting interests between reviewers and other editors, guarantee that the publication process of the manuscripts will be completed in an independent and unbiased manner.
Ethical Responsibilities of Reviewers
The fact that all manuscripts are reviewed through a blind review process has a direct influence on the quality of the publication. This process ensures confidentiality and an objective and independent review. The review process at EJMO is a double blind review. Texts are assigned to the reviewers by the editor. Reviewers do not contact the authors directly; the review and comments are conveyed through a journal management system.
The reviewers doing review work for EJMO bear the following ethical responsibilities: Reviewers must
Ethical Responsibilities of the Publisher
The publisher of EJMO has a non-profit objective. The publisher and the board of EJMO are conscious of the fact that they must observe the ethical responsibilities below and act accordingly:
The publisher undertakes to ensure independent editorial decisions are made without regard to economic or political interests. The editors are the party responsible for the publication process at EJMO and have full and final decision-making authority.
The publisher will protect the intellectual property rights of all the articles published in EJMO and has the responsibility to keep a record of each unpublished article.
The publisher has the responsibility to take precautions against scientific abuse, fraud, and plagiarism.
Notification of any unethical act or improper content in EJMO that departs from the ethical responsibilities described herein may be sent to the journal by e-mail at email@example.com.